If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTarsus Regulatory News (TRS)

  • There is currently no data for TRS

Corporate Update

14 Sep 2009 07:00

RNS Number : 9502Y
Tarsus Group PLC
14 September 2009
 



14 September 2009

Tarsus Group plc

Corporate Update

Tarsus Group plc ('Tarsus' or 'the Group' or 'the Company'), the international business-to-business media group, is pleased to announce the following corporate update for the period since the announcement of its record interim results on 29th July 2009..

France

The Group has disposed of its 50% shareholding in MD Management SAS to its joint venture partner, Reed Exhibitions France, for a net cash consideration of £ 0.4 million. 

This transaction has resulted in a small book profit and continues the strategy of rationalising the Group's portfolio to focus on larger events, with established brands, which tend to be more resilient throughout the economic cycle.

China

Tarsus has entered into an agreement with its joint venture partner Hubei Hope to invest together a further RMB 10 million (approximately £ 0.9 million) of cash into their joint venture, Tarsus Hope.

The monies will be used to fund acquisitions and new launches in the joint venture's core exhibition sectors of medical equipment and industrial equipment in Central China. The investment is conditional on Chinese regulatory approval, but marks a further step in the development of the Group's portfolio of events in one of the fastest growing exhibition markets in the world.

Trading

The Group's second half exhibitions have begun well, with the Off-Price Show in Las Vegas in August and the Medical event in San Jose in September both now currently trading slightly ahead of management's previous expectations.

Importantly, revenues for the two largest exhibitions in Tarsus' portfolio, Labelexpo Europe in September and the Dubai Airshow in November, continue to remain comfortably ahead of the comparable events in 2007. 

Douglas Emslie, Group Managing Director, said:

"We continue to execute against our strategy of increasing our business in the faster growing emerging markets while actively managing our portfolio in our mature markets.

 Trading for the Group for the full year continues to be in line with the Board's expectations and we anticipate a very satisfactory outcome for 2009."

For further information please contact:

Tarsus Group plc

Douglas Emslie, Group Managing Director 020 8846 2700

Ashley Milton, Group Finance Director 020 8846 2700

Media

Matthew Moth, Madano Partnership 020 7593 4000

Investor Relations

Neville Harris, IR Focus 020 7593 4015

Stephen ScottJeremy Wiseman, Scott Harris 020 7653 0030

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLBMITMMTBBLL
Date   Source Headline
9th May 20134:53 pmRNSBlocklisting Interim Review
30th Apr 20135:56 pmRNSHolding(s) in Company
30th Apr 20135:09 pmRNSTotal Voting Rights
30th Apr 20135:09 pmRNSDirector/PDMR Shareholding
17th Apr 20137:15 amRNSAnnual Financial Report
15th Apr 20134:55 pmRNSDirector/PDMR Shareholding
10th Apr 20132:36 pmRNSDirector/PDMR Shareholding
3rd Apr 20135:15 pmRNSDirector/PDMR Shareholding
3rd Apr 201311:49 amRNSTotal Voting Rights and Capital
18th Mar 20136:00 pmRNSHolding(s) in Company
8th Mar 20135:22 pmRNSDirector/PDMR Shareholding
6th Mar 20137:00 amRNSFinal Results
1st Mar 20137:00 amRNSCompletion of Indonesian Acquisition
19th Feb 201310:12 amRNSNotice of Results
30th Jan 20137:30 amRNSAdditional Listing
16th Jan 20137:00 amRNSIndonesian Acquisition
14th Jan 20134:25 pmRNSDirector Declaration
7th Jan 20137:00 amRNSTrading Statement
2nd Jan 20135:09 pmRNSDirector/PDMR Shareholding
20th Dec 20124:00 pmRNSScrip dividend circular
18th Dec 20127:00 amRNSBoard Changes: Non-executive director roles
17th Dec 20127:00 amRNSCompletion of joint venture with GZ Auto
30th Nov 20122:37 pmRNSTotal Voting Rights
15th Nov 20127:00 amRNSInterim Management Statement
9th Nov 20123:25 pmRNSBlocklisting Interim Review
6th Nov 20122:23 pmRNSCompletion of Acquisition
31st Oct 20124:18 pmRNSTotal Voting Rights
25th Oct 20127:00 amRNSAcquisition
17th Oct 201212:08 pmRNSApplication for Admission
28th Sep 20123:25 pmRNSTotal Voting Rights
11th Sep 20121:45 pmRNSInterim Financial Statements 2012
7th Sep 20127:00 amRNSSite Visit
5th Sep 20124:40 pmRNSDirector/PDMR Shareholding
31st Aug 20122:39 pmRNSTotal Voting Rights
20th Aug 20124:13 pmRNSDirector/PDMR Shareholding
25th Jul 20127:00 amRNSHalf Yearly Report
12th Jul 20127:00 amRNSApplication for Admission
6th Jul 201210:08 amRNSNotice of Results
4th Jul 20121:41 pmRNSResult of AGM
29th Jun 20127:00 amRNSPre-Close Trading Statement
28th Jun 20124:40 pmRNSSecond Price Monitoring Extn
28th Jun 20124:35 pmRNSPrice Monitoring Extension
18th Jun 20127:00 amRNSCirc re. Scrip Dividend
15th May 20127:00 amRNSInterim Management Statement
9th May 20124:11 pmRNSBlocklisting Six Monthly Return
9th May 20124:05 pmRNSAnnual Information Update
3rd May 20125:06 pmRNSDirector/PDMR Shareholding
30th Apr 20124:53 pmRNSTotal Voting Rights
25th Apr 20123:42 pmRNSAnnual Report & Accounts and Notice of 2012 AGM
25th Apr 20127:00 amRNSChinese Joint Venture

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.